SEARCH

SEARCH BY CITATION

References

  • Autier, P., and Boyle, P. (2008). Artificial ultraviolet sources and skin cancers: rationale for restricting access to sunbed use before 18 years of age. Nat. Clin. Pract. Oncol. 5, 178179.
  • Baade, P., Meng, X., Youlden, D., Aitken, J., and Youl, P. (2012). Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006. Int. J. Cancer 130, 170178.
  • Bastiaens, M., Hoefnagel, J., Westendorp, R., Vermeer, B., and Bouwes Bavinck, J. (2004). Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Res. 17, 225229.
  • Bataille, V., Sasieni, P., Grulich, A., Swerdlow, A., Mccarthy, W., Hersey, P., Newton Bishop, J.A., and Cuzick, J. (1998). Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int. J. Cancer 78, 812.
  • Bauer, J., Büttner, P., Murali, R., Okamoto, I., Kolaitis, N.A., Landi, M.T., Scolyer, R.A., and Bastian, B.C. (2011). BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 24, 345351.
  • Bishop, D.T., Demenais, F., Iles, M.M. et al. (2009). Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 41, 920925.
  • Bliss, J.M., Ford, D., Swerdlow, A.J., Armstrong, B.K., Cristofolini, M., Elwood, J.M., Green, A., Holly, E.A., Mack, T., and Mackie, R.M. (1995). Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int. J. Cancer 62, 367376.
  • Chang, Y.M., Barrett, J.H., Bishop, D.T. et al. (2009). Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int. J. Epidemiol. 38, 814830.
  • Cress, R.D., Holly, E.A., and Ahn, D.K. (1995). Cutaneous melanoma in women. V. Characteristics of those who tan and those who burn when exposed to summer sun. Epidemiology 6, 538543.
  • Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 21352147.
  • Cust, A.E., Armstrong, B.K., Goumas, C., Jenkins, M.A., Schmid, H., Hopper, J.L., Kefford, R.F., Giles, G.G., Aitken, J.F., and Mann, G.J. (2011). Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int. J. Cancer 128, 24252435.
  • Derancourt, C., Bourdon-Lanoy, E., Grob, J., Guillaume, J., Bernard, P., and Bastuji-Garin, S. (2007). Multiple large solar lentigos on the upper back as clinical markers of past severe sunburn: a case-control study. Dermatology 214, 2531.
  • Fargnoli, M.C., Pike, K., Pfeiffer, R.M. et al. (2008). MC1R variants increase risk of melanomas harboring BRAF mutations. J. Invest. Dermatol. 128, 24852490.
  • Fitzpatrick, T. (1988). The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 124, 869871.
  • Gallagher, R. (2005). Sunbeds – do they increase risk of melanoma or not? Eur. J. Cancer 41, 20382039.
  • Gallagher, R.P., Mclean, D.I., Yang, C.P., Coldman, A.J., Silver, H.K., Spinelli, J.J., and Beagrie, M. (1990). Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch. Dermatol. 126, 770776.
  • Gallus, S., Naldi, L., Carli, P., La Vecchia, C., and Italian Group for Epidemiologic Research in Dermatology (Gised) (2007). Nevus count on specific anatomic sites as a predictor of total body count: a survey of 3,406 children from Italy. Am. J. Epidemiol. 166, 472478.
  • Gandini, S., Sera, F., Cattaruzza, M.S., Pasquini, P., Picconi, O., Boyle, P., and Melchi, C.F. (2005a). Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41, 4560.
  • Gandini, S., Sera, F., Cattaruzza, M.S., Pasquini, P., Zanetti, R., Masini, C., Boyle, P., and Melchi, C.F. (2005b). Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur. J. Cancer 41, 20402059.
  • Garbe, C., Büttner, P., Weiss, J., Soyer, H., Stocker, U., Krüger, S., Roser, M., Weckbecker, J., Panizzon, R., and Bahmer, F. (1994). Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J. Invest. Dermatol. 102, 700705.
  • Gudbjartsson, D.F., Sulem, P., Stacey, S.N. et al. (2008). ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886891.
  • Han, J., Colditz, G.A., and Hunter, D.J. (2006). Risk factors for skin cancers: a nested case-control study within the Nurses’ Health Study. Int. J. Epidemiol. 35, 15141521.
  • Han, J., Kraft, P., Nan, H. et al. (2008). A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 4, e1000074.
  • Héry, C., Tryggvadóttir, L., Sigurdsson, T. et al. (2010). A melanoma epidemic in Iceland: possible influence of sunbed use. Am. J. Epidemiol. 172, 762767.
  • Hölzle, E. (1992). Pigmented lesions as a sign of photodamage. Br. J. Dermatol. 127(Suppl 41), 4850.
  • Kricker, A., Armstrong, B.K., Jones, M.E., and Burton, R.C. (1993). Health, solar UV radiation and environmental change. IARC Technical Report no. 13, Lyon.
  • Landi, M.T., Baccarelli, A., Calista, D., Pesatori, A., Fears, T., Tucker, M.A., and Landi, G. (2001). Combined risk factors for melanoma in a Mediterranean population. Br. J. Cancer 85, 13041310.
  • Landis, J.R., and Koch, G.G. (1977). The measurement of observer agreement for categorical data. Biometrics 33, 159174.
  • Lasithiotakis, K.G., Leiter, U., Gorkievicz, R., Eigentler, T., Breuninger, H., Metzler, G., Strobel, W., and Garbe, C. (2006). The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 107, 13311339.
  • Liang, J.J., Robinson, E., and Martin, R.C. (2010). Cutaneous melanoma in New Zealand: 2000–2004. ANZ J. Surg. 80, 312316.
  • Linos, E., Swetter, S.M., Cockburn, M.G., Colditz, G.A., and Clarke, C.A. (2009). Increasing burden of melanoma in the United States. J. Invest. Dermatol. 129, 16661674.
  • Lock-Andersen, J., Drzewiecki, K.T., and Wulf, H.C. (1998). The measurement of constitutive and facultative skin pigmentation and estimation of sun exposure in Caucasians with basal cell carcinoma and cutaneous malignant melanoma. Br. J. Dermatol. 139, 610617.
  • Maldonado, J.L., Fridlyand, J., Patel, H., Jain, A.N., Busam, K., Kageshita, T., Ono, T., Albertson, D.G., Pinkel, D., and Bastian, B.C. (2003). Determinants of BRAF mutations in primary melanomas. J. Natl Cancer Inst. 95, 18781890.
  • Marrett, L.D., King, W.D., Walter, S.D., and From, L. (1992). Use of host factors to identify people at high risk for cutaneous malignant melanoma. Can. Med. Assoc. J. 147, 445453.
  • Monestier, S., Gaudy, C., Gouvernet, J., Richard, M., and Grob, J. (2006). Multiple senile lentigos of the face, a skin ageing pattern resulting from a life excess of intermittent sun exposure in dark-skinned caucasians: a case-control study. Br. J. Dermatol. 154, 438444.
  • Naldi, L., Lorenzo Imberti, G., Parazzini, F., Gallus, S., and La Vecchia, C. (2000). Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer 88, 27032710.
  • Newton-Bishop, J.A., Chang, Y.M., Elliott, F. et al. (2011). Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur. J. Cancer 47, 732741.
  • Olsen, C.M., Carroll, H.J., and Whiteman, D.C. (2010). Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling. Int. J. Cancer 127, 24302445.
  • Ortonne, J.P. (1990). Pigmentary changes of the ageing skin. Br. J. Dermatol. 122(Suppl 35), 2128.
  • Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O’gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176186.
  • Reeder, A.I., Hammond, V.A., and Gray, A.R. (2010). Questionnaire items to assess skin color and erythemal sensitivity: reliability, validity, and ‘the dark shift’. Cancer Epidemiol. Biomarkers Prev. 19, 11671173.
  • Reguiaï, Z., Jovenin, N., Bernard, P., and Derancourt, C. (2008). Melanoma, past severe sunburns and multiple solar lentigines of the upper back and shoulders. Dermatology 216, 330336.
  • Richtig, E., Ambros-Rudolph, C., Trapp, M., Lackner, H., Hofmann-Wellenhof, R., Kerl, H., and Schwaberger, G. (2008). Melanoma markers in marathon runners: increase with sun exposure and physical strain. Dermatology 217, 3844.
  • Schäfer, T., Merkl, J., Klemm, E., Wichmann, H., Ring, J., and Group, K.S. (2006). The epidemiology of nevi and signs of skin aging in the adult general population: results of the KORA-survey 2000. J. Invest. Dermatol. 126, 14901496.
  • Scherer, D., Nagore, E., Bermejo, J.L., Figl, A., Botella-Estrada, R., Thirumaran, R.K., Angelini, S., Hemminki, K., Schadendorf, D., and Kumar, R. (2009). Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int. J. Cancer 125, 18681875.
  • Suppa, M., Elliott, F., Mikeljevic, J.S. et al. (2011). The determinants of periorbital skin ageing in participants of a melanoma case-control study in the U.K. Br. J. Dermatol. 165, 10111021.
  • Thomson, C.S., Woolnough, S., Wickenden, M., Hiom, S., and Twelves, C.J. (2010). Sunbed use in children aged 11–17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study. Br. Med. J. 340, c877.
  • Whiteman, D.C., Parsons, P.G., and Green, A.C. (1998). p53 expression and risk factors for cutaneous melanoma: a case-control study. Int. J. Cancer 77, 843848.
  • Whiteman, D., Watt, P., Purdie, D., Hughes, M., Hayward, N., and Green, A. (2003). Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl Cancer Inst. 95, 806812.
  • Whiteman, D.C., Pavan, W.J., and Bastian, B.C. (2011). The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res. 24, 879897.